---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-066058"
form_type: "8-K"
ticker: "RIGL"
cik: "0001034842"
company_name: "RIGEL PHARMACEUTICALS INC"
filed_at: "2024-05-29T23:59:59+00:00"
generated_at: "2026-06-01T07:34:46.680845+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Rigel shareholders approve reverse stock split (1:2–1:20) and 6.5M share increase for equity plan

## Summary
- Reverse stock split of common stock at ratio between 1:2 and 1:20 approved; 87.85M for, 42.50M against.
- Amended 2018 Equity Incentive Plan authorized additional 6.5M shares; 53.15M for, 48.24M against.
- Two directors elected: Brian L. Kotzin (78.45M for) and Gregg A. Lapointe (79.15M for) to terms until 2027.
- Advisory say-on-pay approved (74.74M for, 26.22M against); Ernst & Young ratified as auditor for FY2024.
- Adjournment proposal passed (83.11M for) to allow further solicitation if needed for reverse split.

## SEC filing metadata
- accession: 0001104659-24-066058
- form_type: 8-K
- ticker: RIGL
- cik: 0001034842
- company_name: RIGEL PHARMACEUTICALS INC
- filed_at: 2024-05-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1034842/000110465924066058/0001104659-24-066058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1034842/000110465924066058/tm2415798d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-066058
- JSON: https://secwatch.observer/filing/0001104659-24-066058.json
- Plain text: https://secwatch.observer/filing/0001104659-24-066058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.